Fate Therapeutics
+$0.97 (+1.77%) As of 5:24 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.
About FATE
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.
CEO
J. Scott Wolchko
Employees
279
Headquarters
San Diego, California
Founded
2007
FATE Key Statistics
Market Cap
5.31B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.05M
High Today
$56.42
Low Today
$54.24
Open Price
$55.27
Volume
366.77K
52 Week High
$121.16
52 Week Low
$42.64
Analyst Ratings
72%
of 18 ratings
Buy
72.2%
Hold
27.8%
Sell
0%
FATE Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, After Hours